| Kindred Hospice 4776 New Broad St Ste 200, Orlando, FL, 32814 | |
| (407) 599-5079 |
News Archive
Researchers at the Moores Cancer Center at the University of California, San Diego (UCSD) are conducting clinical trials of a novel therapy aimed at revving up the immune system to combat a particularly difficult-to-treat form of leukemia.
Forty-five per cent of Ontarians 65 years and older did not see a dentist in the last year, increasing their risk of chronic diseases and a reduced quality of life , a new study by researchers at St. Michael's Hospital, Women's College Hospital and the Institute for Clinical and Evaluative Sciences (ICES) shows.
Drinking coffee is "more likely to benefit health than to harm it" for a range of health outcomes, say researchers in The BMJ today.
A new case study examining an infant's neurobehavioral abnormalities and extremely high bisphenol A concentration of the baby's mother suggests a link between the two.
Soligenix, Inc., formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today that it has initiated enrollment in its confirmatory Phase 3 randomized, double-blind, placebo-controlled, multicenter clinical trial evaluating orBec(®) for the treatment of acute gastrointestinal Graft-versus-Host disease (GI GVHD).
› Verified 6 days ago
| Name | Kindred Hospice |
|---|---|
| Location | 4776 New Broad St Ste 200, Orlando, Florida |
| Hospice ID | 101540 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Corporation |
| Profit Type | FOR PROFIT |
| SSA county code | 470 |
News Archive
Researchers at the Moores Cancer Center at the University of California, San Diego (UCSD) are conducting clinical trials of a novel therapy aimed at revving up the immune system to combat a particularly difficult-to-treat form of leukemia.
Forty-five per cent of Ontarians 65 years and older did not see a dentist in the last year, increasing their risk of chronic diseases and a reduced quality of life , a new study by researchers at St. Michael's Hospital, Women's College Hospital and the Institute for Clinical and Evaluative Sciences (ICES) shows.
Drinking coffee is "more likely to benefit health than to harm it" for a range of health outcomes, say researchers in The BMJ today.
A new case study examining an infant's neurobehavioral abnormalities and extremely high bisphenol A concentration of the baby's mother suggests a link between the two.
Soligenix, Inc., formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today that it has initiated enrollment in its confirmatory Phase 3 randomized, double-blind, placebo-controlled, multicenter clinical trial evaluating orBec(®) for the treatment of acute gastrointestinal Graft-versus-Host disease (GI GVHD).
› Verified 6 days ago
| NPI Number | 1356504948 |
| Organization Name | Samaritan Care Hospice Of Osceola Inc |
| Address | 1300 N Semoran Blvd Orlando, Florida, 32807 |
| Phone Number | (407)514-1300 |
News Archive
Researchers at the Moores Cancer Center at the University of California, San Diego (UCSD) are conducting clinical trials of a novel therapy aimed at revving up the immune system to combat a particularly difficult-to-treat form of leukemia.
Forty-five per cent of Ontarians 65 years and older did not see a dentist in the last year, increasing their risk of chronic diseases and a reduced quality of life , a new study by researchers at St. Michael's Hospital, Women's College Hospital and the Institute for Clinical and Evaluative Sciences (ICES) shows.
Drinking coffee is "more likely to benefit health than to harm it" for a range of health outcomes, say researchers in The BMJ today.
A new case study examining an infant's neurobehavioral abnormalities and extremely high bisphenol A concentration of the baby's mother suggests a link between the two.
Soligenix, Inc., formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today that it has initiated enrollment in its confirmatory Phase 3 randomized, double-blind, placebo-controlled, multicenter clinical trial evaluating orBec(®) for the treatment of acute gastrointestinal Graft-versus-Host disease (GI GVHD).
› Verified 6 days ago
| NPI Number | 1528439700 |
| Organization Name | Odyssey Healthcare Of Marion County, Llc |
| Address | 4776 New Broad St Ste 200 Orlando, Florida, 32814 |
| Phone Number | (407)514-1300 |
News Archive
Researchers at the Moores Cancer Center at the University of California, San Diego (UCSD) are conducting clinical trials of a novel therapy aimed at revving up the immune system to combat a particularly difficult-to-treat form of leukemia.
Forty-five per cent of Ontarians 65 years and older did not see a dentist in the last year, increasing their risk of chronic diseases and a reduced quality of life , a new study by researchers at St. Michael's Hospital, Women's College Hospital and the Institute for Clinical and Evaluative Sciences (ICES) shows.
Drinking coffee is "more likely to benefit health than to harm it" for a range of health outcomes, say researchers in The BMJ today.
A new case study examining an infant's neurobehavioral abnormalities and extremely high bisphenol A concentration of the baby's mother suggests a link between the two.
Soligenix, Inc., formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today that it has initiated enrollment in its confirmatory Phase 3 randomized, double-blind, placebo-controlled, multicenter clinical trial evaluating orBec(®) for the treatment of acute gastrointestinal Graft-versus-Host disease (GI GVHD).
› Verified 6 days ago
| NPI Number | 1689761868 |
| Organization Name | Hospice Of Integrated Health Services Of District Viib Inc |
| Address | 1300 N Semoran Blvd Orlando, Florida, 32807 |
| Phone Number | (407)514-1300 |
News Archive
Researchers at the Moores Cancer Center at the University of California, San Diego (UCSD) are conducting clinical trials of a novel therapy aimed at revving up the immune system to combat a particularly difficult-to-treat form of leukemia.
Forty-five per cent of Ontarians 65 years and older did not see a dentist in the last year, increasing their risk of chronic diseases and a reduced quality of life , a new study by researchers at St. Michael's Hospital, Women's College Hospital and the Institute for Clinical and Evaluative Sciences (ICES) shows.
Drinking coffee is "more likely to benefit health than to harm it" for a range of health outcomes, say researchers in The BMJ today.
A new case study examining an infant's neurobehavioral abnormalities and extremely high bisphenol A concentration of the baby's mother suggests a link between the two.
Soligenix, Inc., formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today that it has initiated enrollment in its confirmatory Phase 3 randomized, double-blind, placebo-controlled, multicenter clinical trial evaluating orBec(®) for the treatment of acute gastrointestinal Graft-versus-Host disease (GI GVHD).
› Verified 6 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 94.9 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 92.9 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 92.9 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 51.6 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 99.5 | 97.3 |
| Patients who got timely treatment for shortness of breath | 98.1 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 83.3 | 93.3 |
News Archive
Researchers at the Moores Cancer Center at the University of California, San Diego (UCSD) are conducting clinical trials of a novel therapy aimed at revving up the immune system to combat a particularly difficult-to-treat form of leukemia.
Forty-five per cent of Ontarians 65 years and older did not see a dentist in the last year, increasing their risk of chronic diseases and a reduced quality of life , a new study by researchers at St. Michael's Hospital, Women's College Hospital and the Institute for Clinical and Evaluative Sciences (ICES) shows.
Drinking coffee is "more likely to benefit health than to harm it" for a range of health outcomes, say researchers in The BMJ today.
A new case study examining an infant's neurobehavioral abnormalities and extremely high bisphenol A concentration of the baby's mother suggests a link between the two.
Soligenix, Inc., formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today that it has initiated enrollment in its confirmatory Phase 3 randomized, double-blind, placebo-controlled, multicenter clinical trial evaluating orBec(®) for the treatment of acute gastrointestinal Graft-versus-Host disease (GI GVHD).
› Verified 6 days ago
| Home Health Aides | 8 |
| Counselors | 5 |
| Homemakers | 9 |
| Licensed Practical or Vocational Nurses | 6 |
| Medical Social Workers | 6 |
| Registered Nurses | 29 |
| Other Personnel | 7 |
| Total Employees | 70 |
|---|
News Archive
Researchers at the Moores Cancer Center at the University of California, San Diego (UCSD) are conducting clinical trials of a novel therapy aimed at revving up the immune system to combat a particularly difficult-to-treat form of leukemia.
Forty-five per cent of Ontarians 65 years and older did not see a dentist in the last year, increasing their risk of chronic diseases and a reduced quality of life , a new study by researchers at St. Michael's Hospital, Women's College Hospital and the Institute for Clinical and Evaluative Sciences (ICES) shows.
Drinking coffee is "more likely to benefit health than to harm it" for a range of health outcomes, say researchers in The BMJ today.
A new case study examining an infant's neurobehavioral abnormalities and extremely high bisphenol A concentration of the baby's mother suggests a link between the two.
Soligenix, Inc., formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today that it has initiated enrollment in its confirmatory Phase 3 randomized, double-blind, placebo-controlled, multicenter clinical trial evaluating orBec(®) for the treatment of acute gastrointestinal Graft-versus-Host disease (GI GVHD).
› Verified 6 days ago
| Others | 19 |
| Total Volunteers | 19 |
|---|
News Archive
Researchers at the Moores Cancer Center at the University of California, San Diego (UCSD) are conducting clinical trials of a novel therapy aimed at revving up the immune system to combat a particularly difficult-to-treat form of leukemia.
Forty-five per cent of Ontarians 65 years and older did not see a dentist in the last year, increasing their risk of chronic diseases and a reduced quality of life , a new study by researchers at St. Michael's Hospital, Women's College Hospital and the Institute for Clinical and Evaluative Sciences (ICES) shows.
Drinking coffee is "more likely to benefit health than to harm it" for a range of health outcomes, say researchers in The BMJ today.
A new case study examining an infant's neurobehavioral abnormalities and extremely high bisphenol A concentration of the baby's mother suggests a link between the two.
Soligenix, Inc., formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today that it has initiated enrollment in its confirmatory Phase 3 randomized, double-blind, placebo-controlled, multicenter clinical trial evaluating orBec(®) for the treatment of acute gastrointestinal Graft-versus-Host disease (GI GVHD).
› Verified 6 days ago
| Kindred Hospice Location: 4776 New Broad St Ste 200, Orlando, Florida, 32814 Phone: (407) 599-5079 |